BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6847717)

  • 1. Inhibition of hepatic drug metabolism in the rat after Corynebacterium parvum treatment.
    Farquhar D; Benvenuto JA; Kuttesch N; Loo TL
    Biochem Pharmacol; 1983 Apr; 32(7):1275-80. PubMed ID: 6847717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of benzodiazepines on drug-metabolizing enzymes. II. Increased environmental temperature as a modifier of the effect of nitrazepam on microsomal monooxygenases of the rat liver].
    Pachecka J; Kobylińska K; Brozyna M; Bicz W
    Acta Pol Pharm; 1988; 45(3):271-5. PubMed ID: 3239430
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of microsomal drug metabolism by mitochondria and cytochrome c oxidation of extramitochondrial NADPH.
    Tihanyi K; Mészáros K; Horváth I
    Biochem Pharmacol; 1982 Mar; 31(5):661-3. PubMed ID: 6282273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of hepatic delta-aminolevulinic acid synthetase, heme oxygenase, microsomal cytochrome content and drug metabolism in rats bearing ascitic tumors AH 13, AH 66 and AH 414 and a 3-methylcholanthrene induced tumor.
    Matsuura Y; Watanabe H; Fukuda T; Yoshida T; Kuroiwa Y
    J Pharmacobiodyn; 1984 Jul; 7(7):501-10. PubMed ID: 6548516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of hepatic biotransformations by chemical immunoadjuvants.
    Giampietri A; Puccetti P; Contessa AR
    J Immunopharmacol; 1981; 3(2):251-64. PubMed ID: 7338632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
    Augustine JA; Zemaitis MA
    Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid requirement for the induction of microsomal drug-metabolizing enzymes in a rat mutant unable to synthesize ascorbic acid.
    Horio F; Ozaki K; Kohmura M; Yoshida A; Makino S; Hayashi Y
    J Nutr; 1986 Nov; 116(11):2278-89. PubMed ID: 3098936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of drug metabolism by the liver in experimental fascioliasis in the rat.
    Galtier P; Battaglia A; More J; Franc M
    J Pharm Pharmacol; 1983 Nov; 35(11):729-33. PubMed ID: 6139454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of autoxidized linoleic acid on the contents of cytochrome P-450 and cytochrome b5, and drug-metabolizing enzyme activities in rat liver.
    Hiramatsu N; Kishida T; Natake M
    J Nutr Sci Vitaminol (Tokyo); 1987 Feb; 33(1):37-48. PubMed ID: 3612314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PSK, a protein-bound polysaccharide from Coriolus versicolor, on drug-metabolizing enzymes in sarcoma-180 bearing and normal mice.
    Fujita H; Ogawa K; Ikuzawa M; Muto S; Matsuki M; Nakajima S; Shimamura M; Togawa M; Yoshikumi C; Kawai Y
    Int J Immunopharmacol; 1988; 10(4):445-50. PubMed ID: 3139576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [State of the microsomal oxidative system of the rat liver in acute intestinal obstruction].
    Krakovskiĭ ME; Ashirmetov AKh; Komarin AS; Faĭngol'd DIa
    Vopr Med Khim; 1988; 34(3):117-20. PubMed ID: 3420799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic microsomal mixed-function oxidases in rats exposed to high ambient temperature.
    Pachecka J; Kobylińska K; Miaskiewicz H; Bicz W
    Acta Physiol Pol; 1983; 34(5-6):563-8. PubMed ID: 6679992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactone.
    Chapman DE; Holbrook DJ; Chaney SG; Hall IH; Lee KH
    Biochem Pharmacol; 1989 Nov; 38(22):3913-23. PubMed ID: 2512929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sizofilan, an immunomodulator, on hepatic microsomal mixed-function oxidase activities in rats.
    Yomogida S; Koiwai K; Shiba Y; Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1989 Aug; 50(4):499-502. PubMed ID: 2528647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of hepatic microsomal drug-metabolizing enzymes by sulfur-containing metabolites of chlorinated benzenes in rats.
    Kimura R; Kawai M; Sato M; Aimoto T; Murata T
    Toxicol Appl Pharmacol; 1983 Mar; 67(3):338-45. PubMed ID: 6845363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kupffer cell stimulation with Corynebacterium parvum reduces some cytochrome P450-dependent activities and diminishes acetaminophen and carbon tetrachloride-induced liver injury in the rat.
    Raiford DS; Thigpen MC
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):36-45. PubMed ID: 7974494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enzymatic induction in the animal. Measurement of the activity of various hepatic microsomal enzymes].
    Kergueris MF; Larousse C; Guillerme G
    J Pharmacol; 1982; 13(4):585-91. PubMed ID: 7154671
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
    Cha YN; Edwards R
    J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.